EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanocarrier drug delivery system: promising platform for targeted depression therapy

Xiaoying Feng, Ping Jia, Dingding Zhang

Frontiers in Pharmacology · 25.07.2024 · 15

DOI: 10.3389/fphar.2024.1435133 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 25.07.2024. Verfasst von Xiaoying Feng und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, China. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Department of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depression is a chronic mental disorder characterized by persistent low mood and loss of interest. Treatments for depression are varied but may not be sufficient cure. Drug-based treatment regimens have drawbacks such as slow onset of action, low bioavailability, and drug side effects. Nanocarrier Drug Delivery Systems (NDDS) has received increasing attention for brain drug delivery since it assists the drug through the blood-brain barrier and improves bioavailability, which may be beneficial for treating depression. Due to the particle size and physicochemical properties of nanocarriers, it presents a promise to improve the stability and solubility of antidepressants, thereby enhancing the drug concentration. Moreover, ligand-modified nanocarriers can be taken as a target direct medicines release system and reduce drug side effects. The purpose of the present review is to provide an up-to-date understanding of the Nanocarrier drug delivery system and relevant antidepressants in different routes of ingestion, to lay a foundation for the treatment of patients with depression.

Schlagwörter

Stichwörter der Autor:innen

antidepressantsblood-brain barrierdepressiondrug delivery systemnanocarriers

Autor:innen und Institutionen

  • College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Department of Neurosurgery Nursing, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
  • Sichuan Provincial Key Laboratory for Genetic Disease, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.

Förderung

  • Science and Technology Department of Sichuan Province

Zitieren

APA

Feng, X., Jia, P., & Zhang, D. (2024). Nanocarrier drug delivery system: promising platform for targeted depression therapy. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1435133

Vancouver

Feng X, Jia P, Zhang D. Nanocarrier drug delivery system: promising platform for targeted depression therapy. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1435133

BibTeX
@article{Feng2024,
  author = {Feng, Xiaoying and Jia, Ping and Zhang, Dingding},
  title = {Nanocarrier drug delivery system: promising platform for targeted depression therapy},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1435133}
}
Kostenlos starten →